{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:14:36Z","timestamp":1770678876599,"version":"3.49.0"},"reference-count":0,"publisher":"Physicians Postgraduate Press, Inc","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Psychiatry"],"published-print":{"date-parts":[[2001,11,15]]},"DOI":"10.4088\/jcp.v62n1101","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T21:27:29Z","timestamp":1282253249000},"page":"841-842","source":"Crossref","is-referenced-by-count":118,"title":["\"Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 1: \"Goldilocks\" Actions at Dopamine Receptors"],"prefix":"10.4088","volume":"62","author":[{"given":"Stephen M.","family":"Stahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2558","container-title":["The Journal of Clinical Psychiatry"],"original-title":[],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:25:43Z","timestamp":1698755143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.psychiatrist.com\/jcp\/dopamine-system-stabilizers-aripiprazole-next-generation-part-1-goldilocks-actions-dopamine-receptors"}},"subtitle":["(Brainstorms)"],"short-title":[],"issued":{"date-parts":[[2001,11,15]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,11,15]]}},"URL":"https:\/\/doi.org\/10.4088\/jcp.v62n1101","relation":{},"ISSN":["0160-6689"],"issn-type":[{"value":"0160-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11,15]]}}}